COMMUNIQUÉ RÉGLEMENTÉ
News
-
-
COMMUNIQUÉ RÉGLEMENTÉ
bioMérieux strengthens its next-generation sequencing capabilities with the acquisition of Day Zero Diagnostics solutions and technologies
bioMérieux strengthens next-generation sequencing capabilities with acquisition of Day Zero Diagnostics, enhancing rapid diagnostics & antimicrobial stewardship. Acquisition includes NGS workflows, chemistries & software -
COMMUNIQUÉ DE PRESSE
Leclanché Receives Lloyds Register and Bureau Veritas Type Approvals for Navius MRS-3 Marine Rack System
Leclanché's Navius MRS-3 Marine Rack System receives Type Approvals from Lloyd’s Register and Bureau Veritas for meeting safety and performance standards in maritime industry -
COMMUNIQUÉ DE PRESSE
Leclanché reçoit les certificats d’homologation de type de Lloyd’s Register et de Bureau Veritas pour son système de racks marins Navius MRS-3
Leclanché obtient les certificats d'homologation de Lloyd’s Register et Bureau Veritas pour son système de racks marins Navius MRS-3, renforçant ainsi sa position dans le secteur maritime -
-
COMMUNIQUÉ DE PRESSE
Media Release: Sensirion launches new digital humidity and temperature sensors with protective cover
Sensirion launches new digital humidity and temperature sensors with protective cover, SHT40-AD1P-R2 and SHT41-AD1P-R2, offering high accuracy and reliability. Ideal for various applications -
-
-
-
COMMUNIQUÉ DE PRESSE
Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study
Dupixent outperformed Xolair in treating chronic rhinosinusitis with nasal polyps and coexisting asthma, showing superior efficacy across all key endpoints in a phase 4 study presented at EAACI
